Health 3.0: Integration, Trust, and the Future of Healthcare in Mexico

The focus is no longer on building more tools, but on establishing clear rules, aligned incentives, and bold decisions. The potential is vast, but it also raises challenges in responsibility, data use, and decision-making. To this is added limited visibility for the patient regarding decisions that affect their care. Moving forward, the model aims for integration. Ultimately, the differentiator will not be who has the most sophisticated algorithm, but who can generate trust. And trust is not decreed; it is built from the design, with security by default, transparency, clear consent processes, and well-defined rules. Mexico has already begun to move in that direction: the reform published in January 2026 elevated digital health as a public health issue, gave it a legal definition, and opened its own chapter. This is a model where health ceases to be a sequence of isolated events and becomes an integrated, continuous, and preventive experience. Technology has already done its part: it has opened the door. Whoever manages to connect more links will offer a more complete experience, and therefore, one that is harder to replace. In this scenario, healthcare could be concentrated in a single experience: consultation, monitoring, diagnostics, and treatment articulated under the same environment. The medical record ceases to be a static file and becomes a living system, which enables greater prevention and personalization, but also introduces risks. One of the main errors is to treat privacy as an exclusively legal issue and not as part of the service design. The objective is clear: to reduce friction, decrease travel, simplify processes, and improve continuity of care. In essence, it is an architectural change. In the current ecosystem, this redesign is necessary. It remains separate from key actors through layers of intermediation, and when the payer is not the user, incentives are distorted: it becomes difficult to reward quality, continuity, and a good experience. This is the problem that Health 3.0 addresses. However, this evolution has a critical foundation: health information operates with large volumes of data, constant and increasingly sensitive. In a high-connectivity environment, an incident ceases to be technical and becomes an event with human, reputational, and economic consequences. However, the bottleneck is not technological, but one of trust. Therefore, the discussion is not limited to what technology to implement, but to what practices allow this system to be reliable. To this are added deeply human dilemmas. We say — easily — that the patient is at the center of the health system. The actor who adopts Health 3.0 will likely emerge from platforms capable of articulating clinical, technological, and logistical services. It is not an app, nor a wearable, nor “artificial intelligence in health”. Scientific progress will make it possible to know diagnoses that a person did not know — or would prefer not to know, which gives rise to this right, in addition to the need for accompaniment. In practice, this is often not the case. The challenge now is implementation. Health 3.0 is not a distant promise; it is the opportunity to correct fragmentation and, finally, tangibly place the patient at the center. The logic is to connect links that historically operated separately — prevention, diagnosis, care, and financing — so that they function as one. This approach is not defined by a particular technology. All of that can be part of it, but it is not the core. The patient rarely interacts directly with the pharmaceutical or biotechnology industry, and their relationship with hospitals, pharmacies, and health professionals is often conditioned by who assumes the cost of the system. In this context, personalization demands responsibility. Artificial intelligence will be a structural component of this model. What truly defines it is the redesign of relationships: who interacts with whom, who accesses the data, who makes decisions, and who is accountable when something fails. That model not only limits options; it also hinders dynamics that could improve the quality of services. The result is a fragmented system: too many actors, little coordination, and an experience marked by friction, duplications, delays, and lack of continuity. Technologies such as sensors and wearables also allow for a transition from episodic medicine to longitudinal medicine. *Carla Calderon. Lawyer specializing in healthcare regulation and digital health at Baker McKenzie.